News
Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER visit. Raja says not ...
The chart below compares the cost of an annualized semaglutide dosage from Hims, versus competitors: The pivot to liraglutide will allow Hims & Hers to prolong its operations in the weight-loss ...
The Elder Scrolls IV: Oblivion Remastered is finally available ... as it is currently climbing the Steam charts at an exponential rate It should probably be noted that the game was revealed ...
Plus, Bailey Zimmerman adds his fifth top 10. By Jim Asker Morgan Wallen banks his 17th No. 1 on Billboard’s Country Airplay chart as “I’m the Problem” ascends a spot to the top of the ...
As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide ... ensuring proper dosing and pharmaceutical-grade quality.
TARRYTOWN, N.Y. - The U.S. Food and Drug Administration (FDA) has begun Priority Review of Regeneron Pharmaceuticals’ supplemental Biologics License Application for EYLEA HD (aflibercept) Injection 8 ...
The review, announced on April 17, 2025, could lead to the first treatment for retinal vein occlusion (RVO) requiring injections only every eight weeks following an initial monthly dosing period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results